Učitavanje...
Endothelin receptor antagonists in sickle cell disease: a promising new therapeutic approach
Sickle cell disease (SCD) is a genetic hematologic disorder that is characterized by a variety of potentially life threatening acute and chronic complications. Currently, hydroxyurea is the only clinically approved pharmacological therapy for the treatment of SCD, and the continued prevalence of sev...
Spremljeno u:
| Izdano u: | Life Sci |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4992628/ https://ncbi.nlm.nih.gov/pubmed/27049871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2016.04.001 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|